polyene phosphatidylcholine
Small moleculeexperimental
Clinical trial activity
11 trials · 20 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
6
Phase 3
1
Phase 4
3
Earliest trial started Jun 1, 2000 (NCT00211848)
Timeline
Indications
Approved for
Mechanism of action
- Cell membraneSTABILISER
Cell membrane stabiliser
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lipostabil
- lipostabil forte
- polyene phosphatidylcholine
- polyene phosphatidylcholine
- polyene phosphatidyl choline
- polyenylphosphatidylcholine
- polyenylphosphatidylcholine
- polyunsaturated phosphatidylcholine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07303803 | Phase 2 | Jan 1, 2026 | Chipscreen Biosciences, Ltd., Jiao Tong University |
| NCT06922669 | N/A | Jun 24, 2025 | Government of China, Huazhong University of Science and Technology, People's Liberation Army of China, Shandong University, Tianjin Medical University |
| NCT06256445 | Phase 3 | Mar 26, 2024 | AMIpharm Co., Ltd., Chung-Ang University |
| NCT05476094 | Phase 1 | Aug 10, 2022 | AMIpharm Co., Ltd., Seoul National University |
| NCT05266729 | Phase 2 | Mar 2, 2022 | AMIpharm Co., Ltd. |
| NCT04595916 | Phase 4 | Apr 4, 2020 | Haisco Pharmaceutical, Jiao Tong University |
| NCT03982225 | Phase 2 | Jul 1, 2019 | AMIpharm Co., Ltd., Yonsei University |
| NCT02944552 | Phase 2 | Apr 1, 2016 | Drug Induced Liver Disease Study Group |
| NCT02024295 | Phase 4 | Dec 1, 2013 | Capital Medical University, Zhejiang Hisun Pharmaceutical Co. Ltd. |
| NCT01436539 | Phase 4 | Sep 1, 2011 | Capital Medical University, Fujian Cosunter Pharmaceutical Co. Ltd, Sanofi |
| NCT00211848 | Phase 2 | Jun 1, 2000 | Icahn School of Medicine at Mount Sinai, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Roche |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (20)
20 organizations
Page 1 / 1